Kyprolis

KYPROLIS^® Inj. 60mg, 30mg

• Product Name (Korean) 키프롤리스^®주 60mg, 키프롤리스^®주 30mg(카르필조밉)
  
• Product Name (English) Kyprolis^®  Inj. 60mg, Kyprolis^®  Inj. 30mg, (carfilzomib)
  
• Active Ingredient (Korean) 카르필조밉
• Active Ingredient (English) carfilzomib
• API content 60 mg/vial, 30 mg/vial
• Excipients Sulfobutylether Beta-cyclodextrin (SBECD), Anhydrous Citric Acid, Sodium Hydroxide
• Treatment Treatment of multiple myeloma.
• Indications For the treatment of patients with multiple myeloma who have received at least one prior therapy in combination with:
  • Lenalidomide and dexamethasone, or
  • Dexamethasone, or
  • Daratumumab and dexamethasone.
• KYPROLIS^® Inj. 30mg Product information
• KYPROLIS^® Inj. 60mg Product information